Firm Analyst
Marc Frahm, Ph.D.
Michael Schmidt, Ph.D.
Morgan Stanley
Michael Ulz
Raymond James
Dane Leone, CFA

Xilio Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Xilio Therapeutics' performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Xilio Therapeutics or its management. Xilio Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.